Metabolism of docetaxel in mice

Cancer Chemotherapy and Pharmacology

Volumn 56, Issue 3, 2005, Pages 299-306

  Bardelmeijer, Heleen A ^a   Roelofs, Arjan B G H ^a   Hillebrand, Michel J X ^a   Beijnen, Jos H ^a   Schellens, Jan H M ^a   Van Tellingen, Olaf ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Bile; Docetaxel; Feces; Metabolites; Mice

Indexed keywords

CARBOXYL GROUP; DOCETAXEL; DRUG METABOLITE;

ARTICLE; BILE; CONTROLLED STUDY; DIODE; DRUG METABOLISM; DRUG STRUCTURE; FECES; FEMALE; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OXIDATION-REDUCTION; P-GLYCOPROTEIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TAXOIDS;

EID: 21744463061     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0945-4     Document Type: Article

References (15)

1. Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JHM, Beijnen JH, van Tellingen O (2002) Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res 62:6158-6164
2. Bissery MC, Nohynek G, Sanderink GJ, Lavelle F (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6:339-355
3. Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99-114
4. De Valeriola D, Brassine C, Gaillard C, Kettler JP, Tomiak E, Van Vreckem A, Frühling J, Freydman A, Kerger J, Piccart M, Chapelle Ph, Blanc C (1993) Study of excretion balance, metabolism and protein binding of C14 radiolabelled Taxotere in cancer patients. Proc Am Assoc Cancer Res 34:373
5. Extra JM, Rousseau F, Bruno R, Clavel M, Le Bail N, Marty M (1993) Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. Cancer Res 53:1037-1042
6. Gaillard C, Monsarrat B, Vuilhorgne M, Royer I, Monegier B, Sable S, Guenard D, Gires P, Archimbaud Y, Wright M, Sanderink GJ (1994) Docetaxel (Taxotere) metabolism in the rat in vivo and in vitro. Proc Am Assoc Cancer Res 35:428
7. Marlard M, Gaillard C, Sanderink GJ, Roberts S, Joannou P, Faccini V, Chapelle Ph, Freydman A (1993) Kinetics, distribution, metabolism and excretion of radiolabelled Taxotere (14C-RP56976) in mice and dogs. Proc Am Assoc Cancer Res 34:393
8. Marre F, Sanderink GJ, de Sousa G, Gaillard C, Martinet M, Rahmani R (1996) Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans. Cancer Res 56:1296-1302
9. Monegier B, Gaillard C, Sable S, Vuilhorgne M (1994) Structures of the major human metabolites of docetaxel (RP 56976-Taxotere). Tetrahedron Lett 35:3715-3718
10. Monsarrat B, Alvinerie P, Wright M, Dubois J, Gueritte-Voegelein F, Guenard D, Donehower RC, Rowinsky EK (1993) Hepatic metabolism and biliary excretion of Taxol in rats and humans. J Natl Cancer Inst Monogr 39-46
11. Monsarrat B, Mariel E, Cros S, Gares M, Guenard D, Gueritte-Voegelein F, Wright M (1990) Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos 18:895-901
12. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, Nooijen WJ, Beijnen JH, van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 94:2031-2035
13. Sparreboom A, van Tellingen O, Scherrenburg EJ, Boesen JJ, Huizing MT, Nooijen WJ, Versluis C, Beijnen JH (1996) Isolation, purification and biological activity of major docetaxel metabolites from human feces. Drug Metab Dispos 24:655-658
14. van Oosterom AT, Schrijvers D (1995) Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience. Anticancer Drugs 6:356-368
15. Walle T, Walle UK, Kumar GN, Bhalla KN (1995) Taxol metabolism and disposition in cancer patients. Drug Metab Dispos 23:506-512